FDA Rounded out 2019 by Approving a New Treatment for Pancreatic Cancer
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
Tag: Pancreatic cancer
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
A recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...
Philadelphia Eagles player Rodney McLeod he has looked to honor his grandmother’s memory by supporting the American Association for...
Party With a Purpose will honor Penn surgeon Jeffrey Drebin and will donate funds from its gala to the...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Eric R. Lutz, PhD, a recipient of the Pancreatic Cancer Action Network-AACR Career Development Award, studies the development of...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...